Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Successful Securitisation

19 Nov 2007 13:18

Marston's PLC19 November 2007 19 November 2007 Marston's PLC Successful Securitisation Issue Marston's PLC ("Marston's", and together with its subsidiaries the "Marston'sGroup" or "the Group") has finalised the terms of a £330m tap issue of Marston'sIssuer PLC (formerly W&DB Issuer PLC) securitisation. This is backed by thetransfer of 437 freehold and long-leasehold tenanted pubs from thenon-securitised estate to the securitised estate. The pro-forma run-rate EBITDAfor the enlarged securitisation group as at 30 June 2007 was £147.3m.Additionally, Marston's will retain £400m of its existing bank facilities.Following the tap issue only approximately £150m will be drawn against thesefacilities, providing the Group with significant financial and operationalflexibility. The terms of the tap issue are announced today and the transaction is expectedto be completed this week. The refinancing delivers significant benefits toMarston's: • highly competitive ongoing cost of funds with a weighted average margin for the tap issue of 0.80% over Libor, resulting in interest cost of the new issuance of 6.03%, including the costs of hedging.• improves the efficiency of the Group's debt funding, replacing short-term bank borrowing with long term securitised financing.• enhanced operational and financial flexibility within the revised debt structure.• all of the Group's debt is now at effective fixed rates of interest, with no refinancing risk or exposure to volatile credit markets. Marston's tap issue is the only pub securitisation, and one of the very fewsecuritisations in Europe, to have been launched successfully and priced inrecent months. Paul Inglett, Group Finance Director, said "Despite adverse market conditions,the terms of the refinancing demonstrate the strength of Marston's creditprofile and the high quality of its pub estate". The securitisation tap issue has been pre-placed. The pricing of the tap issueis in line with previous pub securitisations and is very competitive given thecurrent difficult conditions in the securitisation markets. The securitisationtap issue priced at the following levels: Tranche Rating (S&P/F) Type Maturity Amount Coupon A4 A/A FRN 2031 £250m Libor + 65 bps1AB1 BBB+/BBB+ FRN 2035 £80m Libor + 125 bps1Total £330m Libor + 80 bps2 Note 1: The FRNs are fully hedged and will be issued at a discount to par priceof 99.95%Note 2: This is the weighted average margin to a step-up in coupon at year 5 As a result of the interest rate swaps put in place in October and the £330m tapof the securitisation, all of the Group's borrowings are now effectively atfixed rates of interest with a blended average cost of debt of approximately6.1%. Marston's will be holding a bondholder presentation on Monday 3rd December at9.30am at the offices of Hudson Sandler, 29 Cloth Fair, London, EC1A 7NN. Pleasecontact Vanessa Laybourn at Hudson Sandler on 020 7796 4133 for details. The Royal Bank of Scotland plc acted as the Arranger, Joint Bookrunner and JointLead Manager in the transaction. HSBC Bank plc is a Joint Bookrunner and JointLead Manager and Barclays Capital is a Joint Lead Manager on the transaction. NMRothschild & Sons Limited advised Marston's on its refinancing strategy. Contact details Marston's PLC Ralph Findlay, Chief Executive 01902 329 516Paul Inglett, Group Finance Director 01902 329 516 The Royal Bank of Scotland plc (Arranger and Joint Bookrunner) Colin Lally, Director 020 7085 6668Paul Crawford, Director 020 7085 5165 NM Rothschild & Sons Limited (Financial Adviser to Marston's) Tom Smyth, Managing Director 020 7280 5719Swagata Ganguly, Assistant Director 020 7280 5676 Hudson Sandler (PR Adviser to Marston's) Andrew Hayes 020 7796 4133Nick Lyon 020 7796 4133 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Oct 20183:21 pmRNSTotal Voting Rights
21st Sep 20183:04 pmRNSHolding(s) in Company
20th Sep 201810:21 amRNSHolding(s) in Company
19th Sep 20188:12 amRNSDirector Declaration
17th Sep 20189:57 amRNSDirector/PDMR Shareholding
6th Sep 20187:00 amRNSAppointment of Chairman
5th Sep 20182:00 pmRNSHolding(s) in Company
21st Aug 20189:07 amRNSHolding(s) in Company
14th Aug 20189:29 amRNSHolding(s) in Company
7th Aug 201812:23 pmRNSDirector/PDMR Shareholding
2nd Aug 20188:46 amRNSDirector Declaration
31st Jul 20187:30 amRNSDirector Declaration
25th Jul 20182:15 pmRNSDirector Declaration
25th Jul 20187:00 amRNSTrading Update
19th Jul 20188:47 amRNSDirector Declaration
10th Jul 20181:38 pmRNSBlock listing Interim Review
3rd Jul 20182:19 pmRNSDirector/PDMR Shareholding
2nd Jul 20182:48 pmRNSTotal Voting Rights
2nd Jul 20189:27 amRNSDirector/PDMR Shareholding
21st Jun 20189:57 amRNSHolding(s) in Company
19th Jun 20183:21 pmRNSDirector/PDMR Shareholding
19th Jun 201811:07 amRNSHolding(s) in Company
12th Jun 201810:13 amRNSDirector/PDMR Shareholding
6th Jun 20181:18 pmRNSDirector/PDMR Shareholding
5th Jun 20187:00 amRNSStatement re analyst site visit
23rd May 201812:09 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSInterim Results for 26 weeks ended 31 March 2018
11th May 201812:38 pmRNSAppointment of Interim Chairman
16th Apr 20189:51 amRNSHolding(s) in Company
3rd Apr 201811:01 amRNSTotal Voting Rights
15th Mar 20187:00 amRNSDirectorate Change
15th Mar 20187:00 amRNSAppointment of Chairman
21st Feb 20184:01 pmRNSHolding(s) in Company
6th Feb 20182:12 pmRNSDirector/PDMR Shareholding
24th Jan 20189:53 amRNSResult of AGM
23rd Jan 20187:00 amRNSTrading update for the 16 weeks to 20 January 2018
10th Jan 201810:07 amRNSBlock listing Interim Review
2nd Jan 20183:54 pmRNSDirector/PDMR Shareholding
2nd Jan 20182:25 pmRNSTotal Voting Rights
20th Dec 20179:42 amRNSDirector Declaration
20th Dec 20177:00 amRNSWilliam Hill appoints Chairman Designate
18th Dec 20174:27 pmRNSAnnual Financial Report
12th Dec 20174:27 pmRNSDirector/PDMR Shareholding
12th Dec 20174:25 pmRNSDirector/PDMR Shareholding
5th Dec 20172:02 pmRNSDirector/PDMR Shareholding
1st Dec 201711:44 amRNSTotal Voting Rights
30th Nov 20177:00 amRNSPreliminary Results
27th Nov 20177:00 amRNSDirectorate
1st Nov 20171:17 pmRNSTotal Voting Rights
10th Oct 20177:00 amRNSYear-End Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.